Doriana Landi Selected Research

Vaccines

3/2023	COVID-19 vaccine hesitancy among Italian people with multiple sclerosis.
1/2023	A specific anti-COVID-19 BNT162b2 vaccine-induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients.
6/2022	Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Doriana Landi Research Topics

Disease

39	Multiple Sclerosis 04/2024 - 02/2016
11	COVID-19 03/2023 - 10/2020
10	Relapsing-Remitting Multiple Sclerosis 04/2024 - 01/2017
5	Progressive Multifocal Leukoencephalopathy 05/2021 - 01/2017
3	Disease Progression 04/2024 - 02/2016
3	Lymphopenia (Lymphocytopenia) 03/2024 - 06/2021
3	Optic Neuritis (Retrobulbar Neuritis) 05/2022 - 01/2021
3	Inflammation (Inflammations) 04/2018 - 01/2017
2	Infections 10/2021 - 10/2020
2	Sudden Infant Death (SID) 05/2021 - 01/2020
1	Optic Nerve Diseases (Optic Neuropathy) 11/2023
1	Viremia 01/2022
1	Opportunistic Infections (Opportunistic Infection) 01/2022
1	Ganglion Cysts (Ganglion) 10/2021
1	Severe Acute Respiratory Syndrome 10/2021
1	Central Serous Chorioretinopathy 01/2021
1	Pneumonia (Pneumonitis) 10/2020
1	Fatigue 03/2020
1	Neuromyelitis Optica (Devic's Disease) 11/2019
1	Bradycardia 11/2019
1	Neuroinflammatory Diseases 11/2019
1	Pain (Aches) 01/2017
1	Immune Reconstitution Inflammatory Syndrome 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2016
1	Stroke (Strokes) 04/2007

Drug/Important Bio-Agent (IBA)

8	Natalizumab (Tysabri)FDA Link 04/2024 - 01/2017
7	ocrelizumabIBA 04/2024 - 10/2020
4	Retinaldehyde (Retinal)IBA 11/2023 - 01/2021
4	Fingolimod Hydrochloride (FTY720)FDA Link 02/2022 - 02/2018
3	Cladribine FDA LinkGeneric 03/2024 - 01/2022
3	VaccinesIBA 03/2023 - 06/2022
3	nitazoxanide (NTZ)FDA Link 09/2022 - 01/2017
3	Dimethyl FumarateIBA 06/2021 - 10/2018
2	COVID-19 VaccinesIBA 03/2023 - 06/2022
2	Messenger RNA (mRNA)IBA 01/2023 - 06/2022
2	Methylprednisolone FDA LinkGeneric 01/2023 - 07/2022
2	Biomarkers (Surrogate Marker)IBA 04/2018 - 02/2016
1	Hormones (Hormone)IBA 10/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	GadoliniumIBA 01/2023
1	BNT162 VaccineIBA 01/2023
1	Contrast MediaIBA 01/2023
1	hydroxide ionIBA 12/2022
1	Vitamin D FDA LinkGeneric 12/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	AntibodiesIBA 01/2022
1	AntigensIBA 10/2021
1	teriflunomideIBA 08/2021
1	mRNA VaccinesIBA 01/2021
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2019
1	Rituximab (Mabthera)FDA Link 11/2019
1	AntioxidantsIBA 11/2019
1	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2019
1	Cholinergic Agents (Cholinergics)IBA 11/2019
1	IronIBA 01/2019
1	Platelet-Derived Growth FactorIBA 04/2018
1	CytokinesIBA 04/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2018
1	SphingosineIBA 02/2018
1	Interferon-betaIBA 01/2017
1	EndocannabinoidsIBA 01/2017
1	Cetirizine (Zyrtec)FDA LinkGeneric 01/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017
1	InterferonsIBA 01/2017
1	SteroidsIBA 01/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2016
1	Indicators and Reagents (Reagents)IBA 04/2007

Therapy/Procedure

12	Therapeutics 04/2024 - 01/2017
2	Aftercare (After-Treatment) 01/2022 - 01/2022
1	Retreatment 01/2022
1	Personal Protective Equipment 10/2020
1	Injections 03/2020
1	Blood Component Removal (Apheresis) 01/2018
1	Plasmapheresis 01/2017